| NEWS OF THE WEEK
Y2K, THE MOLECULE: 5
Concerns about advent of Jan. 1, 2000,
are chemically unsubstantiated. ROCHE LOSES PATENT CASE: 5
Judge rules natural Taq DNA polymerase patent is fraudulent. HAZARDOUS WASTE: 6
Liability and compensation scheme added to international transport treaty. CHEMICAL SAFETY BOARD: 6
Truce declared in long-running feud
between chairman, members. OPIOID ANTAGONIST: 7
Small molecule blocks action of receptor linked to locomotion, learning,
anxiety. MONSANTO SUED: 7
Class-action lawsuit charges company
instigated global cartel in genetically
modified seeds. DEXTER TAKEOVER TARGET: 8
ISP's Heyman offers $900 million for
specialty materials company. BUSINESS
BUSINESS CONCENTRATES: 9
CAPITAL SPENDING: 11
Group of 17 major chemical producers
plan aggregate 5 increase for 2000, but
aggressive DuPont skews that figure.
SNPE IN THE U.S.: 13
French firm takes steps to be a major
player in U.S. fine chemicals.
RESINS FOR DVDs: 14
New discs may require properties beyond those of workhorse polycarbonate.
ENTREPRENEURS: 16
Paralec's founder built a better electronic circuit board.
GOVERNMENT & POLICYGOVERNMENT CONCENTRATES: 18
WORLD TRADE TIMEOUT: 19
Talks in Seattle went nowhere, but work
on a new agenda continues.
JUSTICE DEPARTMENT: 22
Newly appointed science adviser will
support and facilitate policy decisions.
SCIENCE AT STATE: 23
Department sets priorities for environment, science, and technology bureau. SCIENCE/TECHNOLOGY
SCIENCE/TECHNOLOGY CONCENTRATES: 24
ASTROBIOLOGY: 25
NASA advances its ambitious endeavor
to understand how life arose and continues to evolve on Earth. FASTEST SUPERCOMPUTER: 35
Protein folding will be first challenge for
IBM's "Blue Gene." BOOKS
TOMORROW'S MEDICINES: 37
How scientific curiosity, ambition, and
opportunity combine to remake the science and business of medicine. COVER STORY
NATIONAL CHEMISTRY WEEK: 40
Local sections, student affiliates take
science into the community. ACS NEWS
CHEMICAL LANDMARK: 48
Penicillin is recognized as launching a
revolution in disease treatment. MINORITY AFFAIRS: 50
Panel discusses how ACS can work
more closely with advocacy groups. THE DEPARTMENTS
2 LETTERS
3 EDITOR'S PAGE
36 SOFTWARE/ONLINE BRIEFS
51 PEOPLE
52 AWARDS
64 NEWSCRIPTS
Chemical & Engineering News Copyright © 1999 American Chemical Society |